SCHEMBL17213586

SCHEMBL17213586

S=C1CCC(c2ccc(Nc3ncnc4nc[nH]c34)cc2)=NN1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 5/20 0.55
▸ RAB9A P51151 9/20 0.52
▸ NPC1 O15118 8/20 0.52
▸ BRAF P15056 2/20 0.51
▸ TOP2A P11388 2/20 0.51
▸ ROCK1 Q13464 1/20 0.50
▸ SMN1; SMN2 Q16637 7/20 0.49
▸ HTT P42858 5/20 0.49
▸ HSD17B10 Q99714 4/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ EGFR P00533 1/20 0.48
▸ HPGD P15428 4/20 0.48
▸ MAPT P10636 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ TP53 P04637 3/20 0.47
▸ TSHR P16473 2/20 0.46
▸ GFER P55789 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.45
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17213584 0.87 MKNK1 (0.56) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL4926098 0.72 MKNK1 (0.73) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL4923804 0.72 MKNK1 (0.73) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL4922517 0.72 MKNK1 (1.00) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL4921641 0.72 MKNK1 (0.73) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL17213585 0.72 MKNK1 (0.57) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL1060507 0.72 MKNK1 (0.72) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL17213583 0.70 PDE3B (0.52) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL795950 0.69 MKNK1 (0.68) MKNK1RAB9ANPC1BRAFTOP2A
SCHEMBL4913787 0.69 RAB9A (0.72) MKNK1RAB9ANPC1BRAFTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9868744-B2 Heteroaromatic compounds and their use as dopamine D1 ligands PFIZER INC. (US) 2018-01-16 — — US disclosed
US-9688698-B2 Heteroaromatic compounds and their use as dopamine D1 ligands PFIZER INC. (US) 2017-06-27 — — US disclosed
US-20170037053-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS PFIZER INC. (US) 2017-02-09 — — US disclosed
US-20150307522-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS PFIZER INC. (US) 2015-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307522-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS DRD2, DRD1, DRD4 MKNK1 2332/4885RAB9A 616/4885NPC1 542/4885
US-20170037053-A1 HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS DRD2, DRD1, DRD4 MKNK1 2027/4885RAB9A 581/4885NPC1 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback